Lexicon Pharmaceuticals
LXRX
#7253
Rank
โ‚ฌ0.40 B
Marketcap
1,13ย โ‚ฌ
Share price
0.76%
Change (1 day)
62.61%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ98.99 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company has โ‚ฌ98.99 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.22 B48.67%
2023-12-31โ‚ฌ0.15 B19.24%
2022-12-31โ‚ฌ0.12 B68.4%
2021-12-31โ‚ฌ76.59 M-38.13%
2020-12-31โ‚ฌ0.12 B-48.95%
2019-12-31โ‚ฌ0.24 B73.33%
2018-12-31โ‚ฌ0.13 B-45.99%
2017-12-31โ‚ฌ0.25 B-21.37%
2016-12-31โ‚ฌ0.32 B-30.91%
2015-12-31โ‚ฌ0.47 B70.89%
2014-12-31โ‚ฌ0.27 B198.4%
2013-12-31โ‚ฌ93.5 M-44.59%
2012-12-31โ‚ฌ0.16 B-22.21%
2011-12-31โ‚ฌ0.21 B36.67%
2010-12-31โ‚ฌ0.15 B39.92%
2009-12-31โ‚ฌ0.11 B53.79%
2008-12-31โ‚ฌ73.75 M-58.38%
2007-12-31โ‚ฌ0.17 B192.32%
2006-12-31โ‚ฌ60.62 M-27.96%
2005-12-31โ‚ฌ84.15 M30.38%
2004-12-31โ‚ฌ64.54 M-21.89%
2003-12-31โ‚ฌ82.63 M-7.72%
2002-12-31โ‚ฌ89.54 M-47.19%
2001-12-31โ‚ฌ0.16 B-21.19%
2000-12-31โ‚ฌ0.21 B2264.26%
1999-12-31โ‚ฌ9.09 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ2.6 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ7.20 B 7,182.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ0.36 B 266.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.26 B 1,174.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ3.02 B 2,958.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ78.93 M-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.09 B 1,002.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.57 B 483.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.14 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA